Address :INTERSECTION US 13 AND S R 1590 GREENVILLE, NC, 27834, 1887 UNITED STATES | |||
Status : H | Type : A | Woman Owned : N | Business Type : N |
Business Size : E | Primary Business : J | CAO Code : S5111A | ADP Code : HQ0338 |
Part No | Item Name | Manufacturer | NSN | QTY | RFQ |
---|---|---|---|---|---|
NDC00081-0730-58 | neomycin and polymyxin b sulfate | Burroughs Wellcome Co | 6505-01-141-0827 | Avl | RFQ |
NDC00081-0998-30 | allopurinoltablets usp | Burroughs Wellcome Co | 6505-01-153-4333 | Avl | RFQ |
NE0SP0RIN | neomycin and polymy | Burroughs Wellcome Co | 6505-00-890-1299 | Avl | RFQ |
NDC00081-0035-93 | polymyxin b sulfate usp | Burroughs Wellcome Co | 6505-00-913-3124 | Avl | RFQ |
NDC00081-0260-35 | digoxin injection usp | Burroughs Wellcome Co | 6505-01-223-0963 | Avl | RFQ |
NDC00081-0274-55 | digoxin capsules | Burroughs Wellcome Co | 6505-01-165-1483 | Avl | RFQ |
NDC00081-0807-65 | mercaptopurine tablets usp | Burroughs Wellcome Co | 6505-01-153-2871 | Avl | RFQ |
NDC00173-0178-55 | bupropion hydrochloride tablets | Burroughs Wellcome Co | 6505-01-314-6640 | Avl | RFQ |
NDC00081-0178-55 | bupropion hydrochloride tablets | Burroughs Wellcome Co | 6505-01-314-6640 | Avl | RFQ |
NDC00173-0709-01 | mivacurium chloride in dextrose | Burroughs Wellcome Co | 6505-01-356-4835 | Avl | RFQ |
NDC00173-0705-95 | mivacurium chloride injection | Burroughs Wellcome Co | 6505-01-356-4836 | Avl | RFQ |
NDC00501-5104-99 | aluminum hydroxide | Burroughs Wellcome Co | 6505-00-735-1742 | Avl | RFQ |
NDC00081-0725-05 | neomycin and polymyxin b sulfate | Burroughs Wellcome Co | 6505-00-760-2180 | Avl | RFQ |
NDC00081-0264-27 | digoxin elixir usp | Burroughs Wellcome Co | 6505-00-890-1726 | Avl | RFQ |
NDC00081-0820-55 | trimethoprim tablet | Burroughs Wellcome Co | 6505-01-101-2547 | Avl | RFQ |
NDC00081-0201-55 | pyrimethamine tablets usp | Burroughs Wellcome Co | 6505-01-184-9135 | Avl | RFQ |
NDC00081-0875-82 | dextromethorphan hydrobromide g | Burroughs Wellcome Co | 6505-01-275-6053 | Avl | RFQ |
NDC00173-0968-02 | trifluridine ophthalmic solution | Burroughs Wellcome Co | 6505-01-142-8314 | Avl | RFQ |
NDC00081-0856-93 | sulfamethoxazole and trimethopri | Burroughs Wellcome Co | 6505-01-216-1828 | Avl | RFQ |
NDC00081-0242-56 | digoxin tablets usp | Burroughs Wellcome Co | 6505-01-212-4350 | Avl | RFQ |
NDC00081-0991-55 | acyclovir capsules | Burroughs Wellcome Co | 6505-01-206-9246 | Avl | RFQ |
NDC00081-0274-30 | digoxin capsules | Burroughs Wellcome Co | 6505-01-210-2193 | Avl | RFQ |
NDC00081-0940-44 | atracurium besylate injection | Burroughs Wellcome Co | 6505-01-318-1566 | Avl | RFQ |
NDC00081-0993-94 | acyclovir ointment | Burroughs Wellcome Co | 6505-01-137-8451 | Avl | RFQ |
NDC00081-0262-10 | digoxin injection u | Burroughs Wellcome Co | 6505-01-363-1193 | Avl | RFQ |
NDC00081-0274-77 | digoxin capsules | Burroughs Wellcome Co | 6505-01-205-2391 | Avl | RFQ |
NDC00081-0952-01 | acyclovir sodium sterile | Burroughs Wellcome Co | 6505-01-324-9307 | Avl | RFQ |
NE0SR0PIN | bacitracin zinc neomycin sulfate | Burroughs Wellcome Co | 6505-00-836-0768 | Avl | RFQ |
NDC00173-0108-55 | zidovudine capsules usp | Burroughs Wellcome Co | 6505-01-253-2515 | Avl | RFQ |
NDC00081-0763-44 | doxacurium chloride injection | Burroughs Wellcome Co | 6505-01-337-3125 | Avl | RFQ |
81-0730-58 | neomycin and polymyxin b sulfate | Burroughs Wellcome Co | 6505-00-221-3426 | Avl | RFQ |
NDC00173-0952-01 | acyclovir sodium sterile | Burroughs Wellcome Co | 6505-01-324-9307 | Avl | RFQ |
NDC00081-0185-98 | polymyxinbneomyci | Burroughs Wellcome Co | 6505-01-153-3084 | Avl | RFQ |
NDC00081-0945-55 | acyclovir tablets u | Burroughs Wellcome Co | 6505-01-341-9964 | Avl | RFQ |
NDC00081-0249-75 | digoxin tablets usp | Burroughs Wellcome Co | 6505-01-215-4142 | Avl | RFQ |
NDC00173-0855-03 | sulfamethoxazole an | Burroughs Wellcome Co | 6505-01-136-8178 | Avl | RFQ |
NDC00081-0220-75 | aspirin and codeine phosphate ta | Burroughs Wellcome Co | 6505-01-086-1992 | Avl | RFQ |
0081-0797-86 | polymyxin b sulfate and bacitrac | Burroughs Wellcome Co | 6505-00-579-9107 | Avl | RFQ |
NDC00173-0249-55 | digoxin tablets usp | Burroughs Wellcome Co | 6505-01-090-1928 | Avl | RFQ |
NDC00081-0126-62 | atovaquone tablets | Burroughs Wellcome Co | 6505-01-389-9199 | Avl | RFQ |
NDC00081-0018-30 | triprolidine and pseudoephedrine | Burroughs Wellcome Co | 6505-00-117-8608 | Avl | RFQ |
NDC00081-0798-58 | bacitracin zinc and polymyxin b | Burroughs Wellcome Co | 6505-01-153-3486 | Avl | RFQ |
NDC00173-0242-56 | digoxin tablets usp | Burroughs Wellcome Co | 6505-01-212-4350 | Avl | RFQ |
NDC00081-0272-77 | digoxin capsules | Burroughs Wellcome Co | 6505-01-206-9250 | Avl | RFQ |
NDC00081-0166-55 | erythrityl tetranitrate tablets | Burroughs Wellcome Co | 6505-00-727-3211 | Avl | RFQ |
NDC00081-0272-55 | digoxin capsules | Burroughs Wellcome Co | 6505-01-165-1484 | Avl | RFQ |
NDC00081-0045-35 | melphalan tablets u | Burroughs Wellcome Co | 6505-00-912-7457 | Avl | RFQ |
NDC00081-0855-03 | sulfamethoxazole and trimethopri | Burroughs Wellcome Co | 6505-01-158-0851 | Avl | RFQ |
NDC00173-0855-03 | sulfamethoxazole and trimethopri | Burroughs Wellcome Co | 6505-01-158-0851 | Avl | RFQ |
NDC00081-0108-55 | zidovudine capsules | Burroughs Wellcome Co | 6505-01-253-2515 | Avl | RFQ |
All Orders are Fulfilled in the U.S.A.
All shipments must comply with U.S.A export laws.
No exceptions.
The only independent distributor
with a NO CHINA SOURCING Pledge
“We Proudly Support Intrepid Fallen Heroes Fund that serves United States Military Personal experiencing the Invisible Wounds of War : Traumatic Brain Injury (TBI) and Post Traumatic Stress (PTS). Please visit website (www.fallenheroesfund.org) and help in their valiant effort”.
Don’t forget That We offer Same-Day Shipping and 24/7 Service for Our Customers.
Request for Quote